Singapore markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.55+0.32 (+5.14%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
No. of analysts8887
Avg. Estimate-0.24-0.21-0.86-0.03
Low estimate-0.34-0.39-1.43-1.05
High estimate-0.160.160.332.35
Year ago EPS-0.830.11-1.07-0.86
Revenue estimateCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
No. of analysts8887
Avg. Estimate1M12.35M43.24M229.77M
Low estimateN/AN/AN/AN/A
High estimate3.41M91.3M303.8M843.8M
Year ago sales267k236k7.41M43.24M
Sales growth (year/est)274.50%5,133.10%483.50%431.40%
Earnings history29/06/202029/09/202030/12/202030/03/2021
Est. EPS-0.17-0.19-0.22-0.18
Actual EPS-0.830.11-0.14-0.27
Difference-0.660.30.08-0.09
Surprise %-388.20%157.90%36.40%-50.00%
EPS trendCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
Current estimate-0.24-0.21-0.86-0.03
7 days ago-0.19-0.15-0.620.1
30 days ago-0.19-0.15-0.620.52
60 days ago-0.18-0.13-0.590.25
90 days ago-0.19-0.13-0.620.28
EPS revisionsCurrent qtr. (Jun 2021)Next qtr. (Sep 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days5564
Growth estimatesINOIndustrySector(s)S&P 500
Current qtr.71.10%N/AN/AN/A
Next qtr.-290.90%N/AN/AN/A
Current year19.60%N/AN/AN/A
Next year96.50%N/AN/AN/A
Next 5 years (per annum)83.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A